170 related articles for article (PubMed ID: 35724769)
21. COVID-19 and chronic kidney disease: a comprehensive review.
Pecly IMD; Azevedo RB; Muxfeldt ES; Botelho BG; Albuquerque GG; Diniz PHP; Silva R; Rodrigues CIS
J Bras Nefrol; 2021; 43(3):383-399. PubMed ID: 33836039
[TBL] [Abstract][Full Text] [Related]
22. COVID19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection: a population-based cohort stuJune 2020.dy in Southern Catalonia, Spain, March-.
Vila-Corcoles A; Satue-Gracia E; Vila-Rovira A; de Diego-Cabanes C; Forcadell-Peris MJ; Hospital-Guardiola I; Ochoa-Gondar O; Basora-Gallisa J
BMC Public Health; 2021 Oct; 21(1):1795. PubMed ID: 34615512
[TBL] [Abstract][Full Text] [Related]
23. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
24. Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease.
Pilgram L; Eberwein L; Wille K; Koehler FC; Stecher M; Rieg S; Kielstein JT; Jakob CEM; Rüthrich M; Burst V; Prasser F; Borgmann S; Müller RU; Lanznaster J; Isberner N; Tometten L; Dolff S;
Infection; 2021 Aug; 49(4):725-737. PubMed ID: 33851328
[TBL] [Abstract][Full Text] [Related]
25. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study.
Banerjee A; Pasea L; Harris S; Gonzalez-Izquierdo A; Torralbo A; Shallcross L; Noursadeghi M; Pillay D; Sebire N; Holmes C; Pagel C; Wong WK; Langenberg C; Williams B; Denaxas S; Hemingway H
Lancet; 2020 May; 395(10238):1715-1725. PubMed ID: 32405103
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy.
Türk SM; Öztürk Z; Karataş D; Erkorkmaz Ü; Gönüllü E
Turk J Med Sci; 2022 Apr; 52(2):522-523. PubMed ID: 36161620
[TBL] [Abstract][Full Text] [Related]
27. Outcomes among Hospitalized Chronic Kidney Disease Patients with COVID-19.
Khatri M; Charytan DM; Parnia S; Petrilli CM; Michael J; Liu D; Tatapudi V; Jones S; Benstein J; Horwitz LI
Kidney360; 2021 Jul; 2(7):1107-1114. PubMed ID: 35368350
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 infection in children with chronic kidney disease.
Krishnasamy S; Mantan M; Mishra K; Kapoor K; Brijwal M; Kumar M; Sharma S; Swarnim S; Gaind R; Khandelwal P; Hari P; Sinha A; Bagga A
Pediatr Nephrol; 2022 Apr; 37(4):849-857. PubMed ID: 34519896
[TBL] [Abstract][Full Text] [Related]
29. Comorbidity-stratified estimates of 30-day mortality risk by age for unvaccinated men and women with COVID-19: a population-based cohort study.
Abdel-Qadir H; Austin PC; Sivaswamy A; Chu A; Wijeysundera HC; Lee DS
BMC Public Health; 2023 Mar; 23(1):482. PubMed ID: 36915068
[TBL] [Abstract][Full Text] [Related]
30. Association of underlying comorbidities and progression of COVID-19 infection amongst 2586 patients hospitalised in the National Capital Region of India: a retrospective cohort study.
Rana R; Ranjan V; Kumar N; Chugh P; Khillan K; Gogia A; Rana DS; Ganguly NK
Mol Cell Biochem; 2023 Jan; 478(1):149-160. PubMed ID: 35750979
[TBL] [Abstract][Full Text] [Related]
31. The Impact of the COVID-19 Pandemic on Patients With CKD: Systematic Review of Qualitative Studies.
Natale P; Zhang J; Scholes-Robertson N; Cazzolli R; White D; Wong G; Guha C; Craig J; Strippoli G; Stallone G; Gesualdo L; Jaure A
Am J Kidney Dis; 2023 Oct; 82(4):395-409.e1. PubMed ID: 37330133
[TBL] [Abstract][Full Text] [Related]
32. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA.
;
Nephrol Dial Transplant; 2021 Jan; 36(1):87-94. PubMed ID: 33340043
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study.
Jassat W; Cohen C; Tempia S; Masha M; Goldstein S; Kufa T; Murangandi P; Savulescu D; Walaza S; Bam JL; Davies MA; Prozesky HW; Naude J; Mnguni AT; Lawrence CA; Mathema HT; Zamparini J; Black J; Mehta R; Parker A; Chikobvu P; Dawood H; Muvhango N; Strydom R; Adelekan T; Mdlovu B; Moodley N; Namavhandu EL; Rheeder P; Venturas J; Magula N; Blumberg L;
Lancet HIV; 2021 Sep; 8(9):e554-e567. PubMed ID: 34363789
[TBL] [Abstract][Full Text] [Related]
34. Missing Care: the Initial Impact of the COVID-19 Pandemic on CKD Care Delivery.
Diamantidis CJ; Cook DJ; Dunning S; Redelosa CK; Bartolome MFD; Romero RAA; Vassalotti JA
J Gen Intern Med; 2022 Dec; 37(16):4241-4247. PubMed ID: 36163529
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 and chronic kidney disease: an updated overview of reviews.
Jdiaa SS; Mansour R; El Alayli A; Gautam A; Thomas P; Mustafa RA
J Nephrol; 2022 Jan; 35(1):69-85. PubMed ID: 35013985
[TBL] [Abstract][Full Text] [Related]
36. Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control study.
Bouwmans P; Malahe SRK; Messchendorp AL; Vart P; Imhof C; Sanders JF; Gansevoort RT; de Vries APJ; Abrahams AC; Bemelman FJ; Vervoort JPM; Hilbrands LB; Ten Dam MAGJ; van den Dorpel RMA; Rispens T; Steenhuis M; Reinders MEJ; Hemmelder MH;
Int J Infect Dis; 2024 May; 142():106990. PubMed ID: 38428480
[TBL] [Abstract][Full Text] [Related]
37. COVID-19 in patients with chronic kidney disease: a 2-year study of incidence and mortality in relation to the variants of concern waves in Brazil.
Almeida NBF; Filgueiras PS; Lourenço AJ; Bicalho CMF; Corsini CA; de Miranda DAP; Gomes SVC; Vilela RVR; Grenfell RFQ
Trans R Soc Trop Med Hyg; 2023 Aug; 117(8):606-608. PubMed ID: 37042271
[TBL] [Abstract][Full Text] [Related]
38. Identifying subtypes of chronic kidney disease with machine learning: development, internal validation and prognostic validation using linked electronic health records in 350,067 individuals.
Dashtban A; Mizani MA; Pasea L; Denaxas S; Corbett R; Mamza JB; Gao H; Morris T; Hemingway H; Banerjee A
EBioMedicine; 2023 Mar; 89():104489. PubMed ID: 36857859
[TBL] [Abstract][Full Text] [Related]
39. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.
Xiong X; Lui DTW; Chung MSH; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Cheng FWT; Cheung CL; Chan EWY; Lee CH; Woo YC; Tan KCB; Wong CKH; Wong ICK
PLoS Med; 2023 Jul; 20(7):e1004274. PubMed ID: 37486927
[TBL] [Abstract][Full Text] [Related]
40. Mortality and readmission rates among hospitalized COVID-19 patients with varying stages of chronic kidney disease: a multicenter retrospective cohort.
Appelman B; Oppelaar JJ; Broeders L; Wiersinga WJ; Peters-Sengers H; Vogt L;
Sci Rep; 2022 Feb; 12(1):2258. PubMed ID: 35145189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
